Patients' resistance to risk information in genetic counseling for BRCA1/2
- PMID: 15767527
- DOI: 10.1001/archinte.165.5.523
Patients' resistance to risk information in genetic counseling for BRCA1/2
Abstract
Background: Risk information from health care providers is relevant to and used in nearly all medical decisions. Patients often misunderstand their risks, yet little is known about the risk perception that patients derive from risk communications with health care providers. This study examines patients' risk perceptions following communication with health care providers during genetic counseling about the risks of breast cancer and BRCA1/2 mutations.
Methods: A prospective, longitudinal study was conducted from October 2002 to February 2004 of women who received genetic counseling. The women completed a survey before their counseling and a telephone interview in the week after the counseling. Main outcome measures included change from precounseling in risk perception and accuracy of postcounseling risk perception (relative to actual risk information communicated).
Results: A total of 108 women agreed to participate in the study. The women's postcounseling risk perceptions were significantly lower than their precounseling risk perceptions (breast cancer: 17%, P<.001; mutation: 13%, P<.001) but were significantly higher than the actual risk information communicated (breast cancer: 19%, P<.001; mutation: 24%, P<.001). Accuracy of breast cancer risk perception but not mutation risk perception was associated with precounseling worry (P = .04), even after adjusting for trait anxiety (P = .01).
Conclusions: This research demonstrates patients' resistance to risk information. Inappropriately high risk perception derived from a risk communication with a health care provider can lead patients to make different, and potentially worse, medical decisions than they would with an accurate risk perception and to be unnecessarily distressed about their risk.
Similar articles
-
Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.J Womens Health (Larchmt). 2006 Sep;15(7):843-56. doi: 10.1089/jwh.2006.15.843. J Womens Health (Larchmt). 2006. PMID: 16999640 Clinical Trial.
-
Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):1003-7. doi: 10.1158/1055-9965.EPI-03-0545. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15824179
-
Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.Patient Educ Couns. 2007 Jan;65(1):58-68. doi: 10.1016/j.pec.2006.05.006. Epub 2006 Jul 26. Patient Educ Couns. 2007. PMID: 16872788
-
Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk.Oncol Nurs Forum. 2003 Mar-Apr;30(2):241-6. doi: 10.1188/03.ONF.241-246. Oncol Nurs Forum. 2003. PMID: 12692658 Review.
-
Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.Breast J. 2009 Sep-Oct;15 Suppl 1:S56-62. doi: 10.1111/j.1524-4741.2009.00798.x. Breast J. 2009. PMID: 19775331 Review.
Cited by
-
Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.JMIR Res Protoc. 2017 Sep 20;6(9):e184. doi: 10.2196/resprot.8138. JMIR Res Protoc. 2017. PMID: 28931501 Free PMC article.
-
Perceived risk following melanoma genetic testing: a 2-year prospective study distinguishing subjective estimates from recall.J Genet Couns. 2014 Jun;23(3):421-37. doi: 10.1007/s10897-013-9676-1. Epub 2013 Dec 10. J Genet Couns. 2014. PMID: 24322567 Free PMC article.
-
Genetic testing for BRCA1: effects of a randomised study of knowledge provision on interest in testing and long term test uptake; implications for the NICE guidelines.Fam Cancer. 2009;8(1):5-13. doi: 10.1007/s10689-008-9201-0. Epub 2008 Aug 5. Fam Cancer. 2009. PMID: 18679829 Clinical Trial.
-
Personalized Medicine Through SNP Testing for Breast Cancer Risk: Clinical Implementation.J Genet Couns. 2015 Oct;24(5):744-51. doi: 10.1007/s10897-014-9803-7. Epub 2014 Dec 18. J Genet Couns. 2015. PMID: 25519004
-
Knowledge and accuracy of perceived personal risk in underserved women who are at increased risk of breast cancer.J Cancer Educ. 2010 Dec;25(4):617-23. doi: 10.1007/s13187-010-0097-7. J Cancer Educ. 2010. PMID: 20229073 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous